These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 720740)

  • 21. Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension.
    Seedat YK; Seedat MA; Bhoola R
    Curr Med Res Opin; 1977; 4(9):627-9. PubMed ID: 590023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
    Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
    Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potassium supplements.
    Waal-Manning HJ
    N Z Med J; 1982 May; 95(707):326. PubMed ID: 6954394
    [No Abstract]   [Full Text] [Related]  

  • 25. Once daily beta-blocker in hypertension--oxprenolol slow-release.
    Gordon RD; Ziesak M; Rowe WS; Strakosch CR; Row G
    J Int Med Res; 1981; 9(1):6-11. PubMed ID: 7009256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of low versus conventional dose cyclopenthiazide on platelet intracellular calcium in mild essential hypertension.
    McVeigh GE; Copeland S; McKellar J; Johnston D
    J Hypertens; 1988 Apr; 6(4):337-41. PubMed ID: 3288695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: General practitioner studies of beta-blockade in hypertension.
    Forrest WA
    Scott Med J; 1974 Jan; 19(1):49-50. PubMed ID: 4150628
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.
    Bolli P; Simpson FO; Waal-Manning HJ
    Lancet; 1978 Sep; 2(8090):595-8. PubMed ID: 80525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patients.
    Forrest WA
    Br J Clin Pract; 1977 Nov; 31(11):181-6. PubMed ID: 339937
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice.
    Crawford RJ; Allman S; Gibson W; Kitchen S; Richards HH
    J Int Med Res; 1988; 16(2):143-9. PubMed ID: 3378660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Slow trasicor in the treatment of essential hypertension].
    Giec L; Sledziński Z; Trusz-Gluza M; Nieszporek T; Hübner D; Mleczko Z; Olwiński M
    Kardiol Pol; 1981; 24(9):625-30. PubMed ID: 7300086
    [No Abstract]   [Full Text] [Related]  

  • 33. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
    Masoni A; Tomasi AM; Pirani R; Lazzaretto R; Ambroso G
    G Ital Cardiol; 1981; 11(12):2105-9. PubMed ID: 7346306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effect of oxprenolol and chlorthalidone in fixed combination, given once daily.
    Buoninconti R; Motolese M; Rubegni M
    J Int Med Res; 1979; 7(6):519-23. PubMed ID: 391625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: Clinical studies: beta-blockade in systemic hypertension.
    Goldberg AD; Raftery EB
    Scott Med J; 1974 Jan; 19(1):44-5. PubMed ID: 4594823
    [No Abstract]   [Full Text] [Related]  

  • 36. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Toso M; Valori C; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with sustained-release oxprenolol (slow trasicor) in the management of hypertension in general practice.
    Forrest WA
    J Int Med Res; 1979; 7(4):318-23. PubMed ID: 488521
    [No Abstract]   [Full Text] [Related]  

  • 38. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
    Allman S; Norris RJ
    J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment.
    Davies R; Payne NN; Slater JD
    Am J Cardiol; 1976 Mar; 37(4):637-41. PubMed ID: 3963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.
    Kerr MJ; Harron DW; Kinney C; Shanks RG
    Br J Clin Pharmacol; 1981 Dec; 12(6):869-71. PubMed ID: 6122463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.